- Home
- EBON vs RLYB Comparison
EBON vs RLYB Comparison
Compare EBON & RLYB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EBON
- RLYB
- Stock Information
- Founded
- EBON 2010
- RLYB 2018
- Country
- EBON China
- RLYB United States
- Employees
- EBON N/A
- RLYB N/A
- Industry
- EBON Semiconductors
- RLYB Biotechnology: Pharmaceutical Preparations
- Sector
- EBON Technology
- RLYB Health Care
- Exchange
- EBON Nasdaq
- RLYB Nasdaq
- Market Cap
- EBON 24.4M
- RLYB 24.1M
- IPO Year
- EBON 2020
- RLYB 2021
- Fundamental
- Price
- EBON $4.15
- RLYB $0.65
- Analyst Decision
- EBON
- RLYB Hold
- Analyst Count
- EBON 0
- RLYB 2
- Target Price
- EBON N/A
- RLYB N/A
- AVG Volume (30 Days)
- EBON 10.8K
- RLYB 256.0K
- Earning Date
- EBON 08-15-2025
- RLYB 11-06-2025
- Dividend Yield
- EBON N/A
- RLYB N/A
- EPS Growth
- EBON N/A
- RLYB N/A
- EPS
- EBON N/A
- RLYB N/A
- Revenue
- EBON $7,337,066.00
- RLYB $674,000.00
- Revenue This Year
- EBON N/A
- RLYB N/A
- Revenue Next Year
- EBON N/A
- RLYB N/A
- P/E Ratio
- EBON N/A
- RLYB N/A
- Revenue Growth
- EBON 104.28
- RLYB 12.71
- 52 Week Low
- EBON $3.00
- RLYB $0.22
- 52 Week High
- EBON $10.94
- RLYB $1.24
- Technical
- Relative Strength Index (RSI)
- EBON 43.67
- RLYB 57.95
- Support Level
- EBON $4.05
- RLYB $0.61
- Resistance Level
- EBON $4.49
- RLYB $0.65
- Average True Range (ATR)
- EBON 0.27
- RLYB 0.05
- MACD
- EBON -0.03
- RLYB 0.00
- Stochastic Oscillator
- EBON 20.55
- RLYB 59.17
About EBON Ebang International Holdings Inc.
Ebang International Holdings Inc is a blockchain technology and Fintech company, that has ASIC chip design capability. Its business is ASIC chip design and Telecommunication. It operates in a single segment selling bitcoin mining machines and related accessories, telecommunication products, providing cryptocurrency exchange services, management and maintenance services, and cross-border payment and foreign exchange services and rental services. Its geographic regions are Mainland China, and Australia.
About RLYB Rallybio Corporation
Rallybio Corp is a clinical stage biotechnology company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare disorders. The programs of the company are for the prevention of fetal and neonatal alloimmune thrombocytopenia, a potentially life-threatening rare disease that can cause uncontrolled bleeding in fetuses and newborns.